Please assess the completion status of the following clinical trial:

Trial Title: Efficacy and Safety Study of ME-609 and Acyclovir for Treatment of Herpes Simplex Labialis

Study Design Characteristics:
- Allocation: RANDOMIZED
- Intervention Model: PARALLEL
- Observational Model: None
- Primary Purpose: PREVENTION
- Time Perspective: None
- Masking: DOUBLE
- Phase: PHASE3
- Number of Arms: 3.0

Eligibility Criteria:
Inclusion Criteria:~* Generally good health~* History of recurrent herpes labialis with at last three episodes during the prior 12 months~Exclusion Criteria:~* Treatment with antivirals or immunosuppressive agents within 2 weeks prior to randomization~* Pregnant and/or nursing women~* Continuous daily treatment with pain medication~* Significant skin condition that occur in the area of herpes recurrences

- Gender: ALL
- Minimum Age: 18 Years
- Maximum Age: None
- Healthy Volunteers: f

Study Arms:
- 1 (Type: EXPERIMENTAL): ME-609
- 2 (Type: ACTIVE_COMPARATOR): Acyclovir in ME-609 vehicle
- 3 (Type: PLACEBO_COMPARATOR): Vehicle

Based on this trial design, predict the completion outcome and termination type (if applicable).